ASX - By Stock
|
BIT |
Re:
Ann: BIOTRON CLINICAL TRIAL RESULTS WEBINAR
|
|
mark12
|
151 |
44K |
3 |
25/06/24 |
25/06/24 |
ASX - By Stock
|
151
|
44K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Shareholder Update
|
|
mark12
|
271 |
85K |
5 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
271
|
85K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
mark12
|
1.6K |
498K |
3 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
1.6K
|
498K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
mark12
|
1.6K |
498K |
4 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
1.6K
|
498K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
mark12
|
1.6K |
498K |
1 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
1.6K
|
498K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Results of AGM
|
|
mark12
|
199 |
57K |
7 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
199
|
57K
|
7
|
|
ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
mark12
|
1.6K |
498K |
1 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
1.6K
|
498K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mark12
|
13K |
6.4M |
1 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
13K
|
6.4M
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Results of AGM
|
|
mark12
|
199 |
57K |
3 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
199
|
57K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation to Annual General Meeting
|
|
mark12
|
62 |
20K |
3 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
62
|
20K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Letter to Shareholders
|
|
mark12
|
381 |
120K |
1 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
381
|
120K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Letter to Shareholders
|
|
mark12
|
381 |
120K |
10 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
381
|
120K
|
10
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
mark12
|
5.0K |
1.4M |
2 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
5.0K
|
1.4M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
mark12
|
1.6K |
498K |
1 |
27/10/23 |
27/10/23 |
ASX - By Stock
|
1.6K
|
498K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
mark12
|
174 |
47K |
14 |
27/10/23 |
27/10/23 |
ASX - By Stock
|
174
|
47K
|
14
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation to Investors
|
|
mark12
|
131 |
43K |
2 |
24/10/23 |
24/10/23 |
ASX - By Stock
|
131
|
43K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation to Investors
|
|
mark12
|
131 |
43K |
9 |
24/10/23 |
24/10/23 |
ASX - By Stock
|
131
|
43K
|
9
|
|
ASX - By Stock
|
BIT |
Re:
BITOC
|
|
mark12
|
68 |
22K |
0 |
20/10/23 |
20/10/23 |
ASX - By Stock
|
68
|
22K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
mark12
|
1.6K |
498K |
0 |
20/10/23 |
20/10/23 |
ASX - By Stock
|
1.6K
|
498K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
mark12
|
1.6K |
498K |
1 |
17/10/23 |
17/10/23 |
ASX - By Stock
|
1.6K
|
498K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Dear Dr Miller and Company Directors ,
|
|
mark12
|
89 |
23K |
6 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
89
|
23K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
mark12
|
5.0K |
1.4M |
5 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
5.0K
|
1.4M
|
5
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
mark12
|
5.0K |
1.4M |
34 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
5.0K
|
1.4M
|
34
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mark12
|
13K |
6.4M |
0 |
26/08/22 |
26/08/22 |
ASX - By Stock
|
13K
|
6.4M
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
mark12
|
472 |
186K |
13 |
30/05/22 |
30/05/22 |
ASX - By Stock
|
472
|
186K
|
13
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mark12
|
13K |
6.4M |
6 |
11/05/22 |
11/05/22 |
ASX - By Stock
|
13K
|
6.4M
|
6
|
|
ASX - By Stock
|
BIT |
Re:
chart daily
|
|
mark12
|
3.2K |
1.0M |
3 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
3.2K
|
1.0M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ten Bagger
|
|
mark12
|
106 |
47K |
2 |
02/05/22 |
02/05/22 |
ASX - By Stock
|
106
|
47K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Ann: BIT225 EFFECTIVE AGAINST ESTABLISHED SARS-CoV-2 IN ANIMALS
|
|
mark12
|
178 |
75K |
5 |
02/05/22 |
02/05/22 |
ASX - By Stock
|
178
|
75K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mark12
|
13K |
6.4M |
3 |
02/05/22 |
02/05/22 |
ASX - By Stock
|
13K
|
6.4M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
FDA application made for fast track for COVID-19
|
|
mark12
|
275 |
100K |
9 |
22/03/22 |
22/03/22 |
ASX - By Stock
|
275
|
100K
|
9
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: Ceasing to be a substantial holder
|
|
mark12
|
38 |
10K |
2 |
08/03/22 |
08/03/22 |
ASX - By Stock
|
38
|
10K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Biotron's Phenomenal Success ...
|
|
mark12
|
146 |
49K |
4 |
14/02/22 |
14/02/22 |
ASX - By Stock
|
146
|
49K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Biotron's Phenomenal Success ...
|
|
mark12
|
146 |
49K |
3 |
05/02/22 |
05/02/22 |
ASX - By Stock
|
146
|
49K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
covid news
|
|
mark12
|
248 |
77K |
0 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
248
|
77K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
covid news
|
|
mark12
|
248 |
77K |
0 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
248
|
77K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
covid news
|
|
mark12
|
248 |
77K |
3 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
248
|
77K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
mark12
|
60 |
20K |
8 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
60
|
20K
|
8
|
|
ASX - By Stock
|
ZIP |
Re:
Daily Price Movement / General Discussion
|
|
mark12
|
46K |
11M |
8 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
46K
|
11M
|
8
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: Becoming a substantial holder
|
|
mark12
|
17 |
6.9K |
5 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
17
|
6.9K
|
5
|
|
ASX - By Stock
|
ZIP |
Re:
36% of BNPL users missed a payment, 57% spent above their means
|
|
mark12
|
54 |
13K |
4 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
54
|
13K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mark12
|
13K |
6.4M |
5 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
13K
|
6.4M
|
5
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: Response to Media Speculation
|
|
mark12
|
240 |
67K |
13 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
240
|
67K
|
13
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mark12
|
13K |
6.4M |
7 |
23/01/22 |
23/01/22 |
ASX - By Stock
|
13K
|
6.4M
|
7
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mark12
|
13K |
6.4M |
4 |
21/01/22 |
21/01/22 |
ASX - By Stock
|
13K
|
6.4M
|
4
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mark12
|
13K |
6.4M |
0 |
19/01/22 |
19/01/22 |
ASX - By Stock
|
13K
|
6.4M
|
0
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mark12
|
13K |
6.4M |
8 |
18/01/22 |
18/01/22 |
ASX - By Stock
|
13K
|
6.4M
|
8
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mark12
|
13K |
6.4M |
12 |
18/01/22 |
18/01/22 |
ASX - By Stock
|
13K
|
6.4M
|
12
|
|
ASX - By Stock
|
BIT Biotech |
Re:
Biotron Share Price Competition Jan 1 2022
|
|
mark12
|
408 |
139K |
3 |
14/01/22 |
14/01/22 |
ASX - By Stock
|
408
|
139K
|
3
|
|
ASX - By Stock
|
BIT Biotech |
Re:
Biotron Share Price Competition Jan 1 2022
|
|
mark12
|
408 |
139K |
0 |
14/01/22 |
14/01/22 |
ASX - By Stock
|
408
|
139K
|
0
|
|